Reactivation of the BK polyomavirus is known to lead to severe complications in kidney transplant patients. 18 The current treatment strategy relies on decreasing the immunosuppression to allow the immune system to 19 clear the virus. Recently, we demonstrated a clear association between the resolution of BKV reactivation and 20 reconstitution of BKV-specific CD4 + T-cells. However, which factors determine the duration of viral infection 21 clearance remains so far unclear. Here we apply a combination of in-depth multi-parametric flow cytometry 22
Introduction
32 Immunosuppression is one of the most important factors contributing to reactivation of the latent BK 33 polyomavirus (BKV) (1) . In fact, BKV reactivation can be observed in up to 80% of all kidney-transplant 34 recipients (2). In as many as 10% of the cases, patients develop BKV-associated nephropathy (BKVAN) 35 which can lead to graft loss (2). Currently, there is no antiviral treatment for BK virus available and the 36 recommended approach to management of BKVAN is a reduction or modification of immunosuppression, in 37 order to achieve sufficient antiviral control by cellular immunity (1, 3) . In fact, we and others previously 38 demonstrated a strong decrease of the BKV load upon reconstitution of BKV-specific T-cells in renal 39 transplant patients (4,5). Very recently, we demonstrated an improved strategy for monitoring of BKV-specific 40 T-cells by multi-parameter flow cytometry and provided in-depth characteristics of BKV-specific T-cells 41 associated with the initiation of BKV load decline (6). 42
Although the essential role of BKV-specific T-cells for the initiation of BKV load decline has been well 43 documented, it is so far not clear, which factors determine the clinical course of the disease. The time it takes 44 to clear BKV differs between patients, and the clearance time after severe BKV infection (BKV load more 45 than 100,000 copies/ml) can span weeks to even years (7, 8) . On the other hand, sustained BKV infection can 46 cause immunopathogenesis and lead to irreversible renal graft tissue damage and graft failure (1) . Therefore, 47 understanding the factors that determine the clearance time once BKV load starts declining is crucial for 48
understanding the pathogenesis of BKV-associated nephropathy and for improving therapeutic management in 49 patients with BKV reactivation. 50
Besides the magnitude and functional activity of antigen-specific T-cells, the heterogeneity of clonal repertoire 51 of antigen-specific T-cells has been suggested to play an important role in the immune defense. Pathogen 52 recognition by T-cells is established through the T-cell receptor (TCR) specific for a cognate epitope in 53
context of the HLA-molecule (9). T-cells with the same progenitor bear identical TCRs and constitute a T-cell 54 clone. Recent studies suggest that diversity and size of the antigen-specific TCR repertoire are two critical 55 determinants for the successful control of chronic infections and the decreased repertoire diversity correlates 56 with the decline of immune responsiveness in ageing (10). Although a young adult human might harbor more 57 than 100 million different TCRs (11), only a small fraction is specific for a given pathogen (12). Despite the 58 low frequency, the identification and tracking of antigen specific TCRs are emerging as valuable tools in the 59 analysis of organ rejection and control of persistent infections (13) (14) (15) . 60
In the present work we provide a further characterization of BKV-specific T-cells using the combination of 61 multi-parameter flow cytometry, cell sorting, and NGS-based clonotype profiling. By means of these 62 comprehensive analyses in a small cohort of patients with different course and duration of BKV infection, we 63 identified immunological factors that influence the length of the clearance time. We found a strong correlation 64 between the BKV clearance time and TCR repertoire diversity as well as the expression of exhaustion markers 65 on the surface of BKV-specific T-cells. 66
2
Material and Methods 67
Study cohort 68
This study was approved by our local ethical review committee in compliance with the declaration of Helsinki. 69
Informed and written consent was obtained from all patients (Ethic Committee Charité University Medicine,  70 Berlin, Germany, EA2/028/13). The study cohort consisted of 7 kidney transplant recipients with sustained 71 BKV reactivation ( Table 1 ). The HLA typing for each patient and donor is summarized in Figure 1 . 72 73 BKV-DNA copy numbers were determined in serum as previously described (16). Briefly, DNA was isolated 74 from serum using a QIAamp DNA Mini Kit (Qiagen) according to the manufacturer's instructions. Primers 75 and probes were designed to amplify the VP1 region of BKV. A plasmid standard containing the VP1 coding 76 region was used to determine the copy number per ml. Samples exceeding the detection level (>1000 77 copies/ml) were considered positive. 78 79 PBMC were isolated from 40 ml freshly drawn heparin-treated peripheral blood using the Ficoll-Hypaque 80 (PAA Laboratories) gradient method and collected in RPMI-1640 medium (supplemented with L-glutamine (2 81 mmol/l), fetal calf serum (10%), penicillin (100 IU/ml), and streptomycin (0.1 mg/ml), all from Biochrom) and 82 stimulated with overlapping peptides of all viral products as previously described (17). Briefly, an overlapping 83 peptide pool was created from individual 15mer BKV peptides with an 11 amino acids overlap of the BKV 84 proteins VP1 (Swiss-Prot ID : P14996), VP2 (Swiss-Prot ID : P03094), VP3 (P Swiss-Prot ID : 03094-2), 85 small T antigen (Swiss-Prot ID : P03082) and large T antigen (Swiss-Prot ID : P14999). Although VP3 and 86 small T antigen are included in the ORF of VP2 and large T antigen, respectively, both peptides are included 87
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in the overlapping peptide pool to address the shift in the starting position and to mimic the relative abundance 88 of the epitopes. The scheme of the 15mer 11 overlapping peptide pools is illustrated in Figure S1 in 89 Supplementary Material. 90
All individual peptide pools (JPT) were reconstituted in DMSO and phosphate-buffered saline (PBS) to 1.5 91 mM (2.5µg/µl) for each peptide. 0.5-1 × 10 7 PBMCs were incubated with the BKV overlapping peptide pool 92 at final concentration of 1 µg peptide/ml for 16 h at 37 °C, 5% CO 2 . Brefeldin A (Sigma-Aldrich) was added 93 at 1 μg/ml after 2 hours. 94 2.4 Antibodies and staining procedure 95 Cells were stained with anti-CD3-eF650 (Clone: UCHT1; eBioscience), anti-CD4-PerCP/Cy5.5 (Clone: SK3; 96 BD Bioscience), anti-CD8-BV570 (Clone: 3B5; Invitrogen), and Live/Dead NearIR (Invitrogen). The surface 97 staining was performed in PBS for 15 minutes at room temperature in the dark and subsequently fixed using 98
Permeabilizing Solution 2 (BD Biosciences) for 10 minutes at room temperature. 99
Intracellular staining was performed with anti-CD137-PE/Cy5 (Clone: 4B4-1; BD Biosciences), anti-CD154-100 APC/Cy7 (Clone: 24-31; Biolegend), anti-PD1-BV710 (Clone: EH12.2H7; Biolegend), and anti-TIM3-APC 101 (Clone: F38-2E2; eBioscience) for 30 minutes at room temperature in the dark. 102
Samples were acquired on a LSRII-Fortessa (BD Biosciences) and at least 1.5 × 10 6 events were recorded. 103
Calibration of the instrument was reconfirmed weekly with rainbow beads (BD Biosciences). 104 105 T-cells were sorted by flow cytometry according to CD4 and CD8 expression from unstimulated PBMCs 106 stained with anti-CD3-eF650 (Clone: UCHT1; eBioscience), anti-CD4-PerCP/Cy5. 
TCR repertoire analysis
Diversity estimation 131
To account for differences in sequence depth, the clonotypes were rarified to equal sample size before 132 estimation of repertoire diversity. Rarefaction was performed using the R-package vegan, version 2.4-3 (20). 133
The Shannon index (21) is given by 134
where p i is the proportion of the ith clonotype in the population. 135
The Berger-Parker index (22) is given by 136 = where N A indicates the abundance of the most abundant clonotype, N T is the total number of clonotypes. This 137 index relies on the most abundant clonotype and is therefore less sensitive to sequencing errors. 138 139 Patients were considered free from BKV viremia if at least two consecutive measurements were below 140 detection limit. The time from the highest viral load until complete virus clearance was estimated from the 141 slope of the linear fit of the log-transformed measurements spanning from the highest BKV copy number to 142 the first BKV viremia free measurement. The initial conditions for the clearance time estimation were the 143 highest measured viremia level: 144
Estimation of clearance time
where BKV min is the detection limit of 1000 BKV copies/ml. 145 146 Flow cytometry data was analyzed using FlowJo version 10.3 (Tree Star). Statistical analysis was performed 147 using R, version 3.3.1 (23). p values < 0.05 were considered significant. 148 3 Results
Statistical analysis
149
BKV viremia clearance time differs between kidney transplant recipients 150
BKV viremia was monitored in kidney transplant patients with BKV reactivation (Figure 2 ). The highest 151 measured BKV copy number followed by load decline was taken as the start of the viremia clearance phase. 152
The patient was considered free from BKV viremia when samples from at least two consecutive time points 153
were both negative. The first of these time points marked the end of the viremia clearance phase. The actual 154 clearance is at a point before the observed clearance. To limit the effect of sampling frequency, we sought to 155 obtain a data driven length of the viremia clearance phase by linear regression on log-transformed BKV viral 156 load. The slope of the fitted curve was used the slope to estimate the number of days until the virus was 157 cleared. The linear fit explained 78 to 96% of the variation in the viremia decline phase (Figure 2A ). The 158 estimated clearance time ranged between 46 and 298 days ( Figure 2B ). The time with increasing BKV 159 viremia was similarily estimated through linear regression ( Figure 2C ). No association bethween the length of 160 the inclining and declining phase was found (data not shown). 161
Magnitude and phenotypic characteristics of BKV-specific T-cells do not explain
162 differences in BKV clearance time 163 Previously, we showed that the BK viral load decline was associated with the reconstitution of helper and 164 cytolytic BKV-specific T-cells in peripheral blood (6). However, the factors that affect the BKV infection 165 clearance time were so far not addressed. Here, we analyzed the effect of functional and phenotype 166 characteristics on the duration of BKV clearance ( Figure 3A , Figure S2 -S8 in Supplementary Material). First, 167
using the previously published gating strategy and activation markers CD137/CD154 for CD4 + T-cells and 168 CD137/Granzyme B for CD8 + T-cells (6), the frequencies of BKV-specific CD4 + and CD8 + T-cells circulating 169
in peripheral blood were evaluated. No correlation between the duration of BKV clearance time and the ratio 170 of either BKV-specific CD4 + or CD8 + T-cells at the peak of viral load could be observed ( Figure 3B and C).
171
The frequencies of total CD4+ or CD8+ also did not correlate with the clearance time ( Figure S9A and B in 172
Supplementary Material). 173
Since previous data demonstrated a better antiviral control in patients with elevated number of multi-174 functional cells (17), we next addressed the question whether functionality of BKV-specific T-cells could 175 explain the difference in clearance time. To this end we analyzed multi-functional characteristics of BKV-176
specific T-cells as defined by multiple cytokine production (IL2, TNFα and IFNγ) and/or effector molecule 177 Granzyme B. The analysis of BKV-specific cytokine multifunctional and effector molecule producing 178 capacities did not reveal any influence on duration of clearance period ( Figure S9C and D in Supplementary  179 Material). 180
Tracking of BKV-specific TCRs
181
Previous studies on the protective function of cellular immunity in cancer suggest an important role of the 182 TCR repertoire (24, 25 Addressing this question, we analyzed BKV-specific T-cells on a single clone level during BKV clearance. 185
We have previously used NGS-based clonotype profiling to identify BKV-specific T-cell clones and track 186 them in peripheral blood, renal tissue biopsy, and urine (18). Using a similar approach, we were able to study 187 the kinetics of BKV-specific T-cells on the clonal level of whole blood-derived CD4 + and CD8 + T-cell subsets 188 in the current study ( Figure 4 ). Antigen specific clonoypes within whole-blood samples were identified by 189 identity to BKV-specific clonotype sequences obtained by the IFNγ Secretion Assay. The distribution of 190 length TCRβ CDR3 of these BKV-specific clonotypes had a similar shape for all patients and was normally 191 distributed in all cases ( Figure S10 in Supplementary Material). A tendency for slightly longer CDR3 was 192 observed for patient 3 (17 AA on average compared to 15 AA for the others; Table S1 in Supplementary  193 Material). However, the most abundant length for the patients was 15 AA. 194
The TCRβ V-segment V6 dominated the BKV-specific clonotypes in all patients. The segment V7 was also 195 dominant in the patients 1 and 7 ( Figure S11A in Supplementary Material). The J-segment J2-1 was found to 196 be frequent in all patients, but also J1-1 and for patient 5 the J1-6 were also present ( Figure S11B 213 We next asked how the TCR repertoire diversity of BKV-specific T-cells reflected the differences in clearance 214 time. We first evaluated the commonly used Shannon index, but found no pattern associating with the 215 clearance time ( Figure 5A ). Berger-Parker is another diversity index, which disregards the clonotypes with 216 very low frequency (that is the tail of the distribution), and can therefore be considered a more robust index 217 (28). When we looked at inverse of the Berger-Parker indexwhich directly reflects the clonal diversity of an 218 analyzed populationwe found a strong correlation to the clearance time ( Figure 5B , Figure S12D 231 Patient 3 clearly rejected the observed pattern. This particular patient showed a fast BKV load decline but a 232 very low level of BKV-specific TCR repertoire diversity ( Figure 5B ). We therefore asked whether the 233 expansion of few BKV-specific clones could explain this aberrant behavior. We reasoned that any expansion 234 in vivo would be reflected in expanded levels of antigen specific T-cells and performed, consequently, in-235 depth characterization of BKV-specific T-cell immunity in this patient by flow cytometry. Of interest, we 236 detected very high frequencies of BKV-specific CD4 + and CD8 + T-cells in peripheral blood of patient 3; the 237 magnitude of the T-cell response was almost 10 times higher compared to the frequencies among the other 238 patients ( Figure 5C ). 239 240 In addition to the demonstrated correlation between repertoire diversity and clearance time, we also evaluated 241 the role of functional exhaustion of BKV-specific T-cells. Flow cytometric analysis of the exhaustion markers 242 PD1 and TIM3 on CD4 + T-cells demonstrated a very strong correlation between the expression of these 243 markers on BKV-specific CD4 + T-cells and the clearance time ( Figure 5D ). Interestingly no association to co-244 expression of PD1 and TIM3 was observed ( Figure S13C in Supplementary Material). No expression of 245 either exhaustion marker was seen among BKV-specific CD8 + T-cells ( Figure S13A and B in Supplementary   246 Material). Our data thus show that exhaustion of the CD4 + T-cells is associated with extended clearance time. 247
Low diversity of BKV-specific clonotypes indicates prolonged clearance time
Activation can counteract low diversity
Prolonged clearance time correlates with expression of exhaustion markers
Discussion
248
The present study provides characterization of BKV-specific T-cells in a small cohort of renal transplant 249 recipients. In line with previous reports (7,8), we observed significant differences in clearance time of BKV 250 virus. We used modern high throughput technologies such as next generation sequencing and multi-parameter 251 flow cytometric analysis to address the question how the fitness of the immune system affects the BKV 252 clearance time. Here, we presented evidence that the diversity of the BKV-specific TCR repertoire inversely 253
correlates with the duration of BKV clearance from initiation of the load decline until virus clearance. In 254 addition, we showed that the expression of exhaustion markers PD1 and TIM3 on BKV-specific CD4 + T-cells 255 at the time point of initial BKV load decline correlates with sustained BKV reactivation, while lack of the PD1 256 and TIM3 expression corresponded to shorter clearance time. These data therefore suggest that the repertoire 257 diversity and functional fitness of BKV-specific T-cells as defined by the expression of exhaustion markers 258
are key players in determining the clinical course of viral infection and clearance. 259
The essential role of T-cells in controlling BKV reactivation and clearance is well established. We have 260 previously shown that the loss of BKV-specific T-cells is associated with a higher risk of BK viremia (29) and 261 that an increase in BKV-specific T-cell response corresponded to the clearance of BKV reactivation (4). The 262 current recommendation for the management of BKV infection in renal transplant patients includes 263 accordingly a reduction or modification of immunosuppressive therapy allowing for an immune system 264 reconstitution. In fact, frequencies of BKV-specific T-cells increase upon reduction of immunosuppression as 265 demonstrated previously (5,30). However, despite similar therapeutic approaches, the duration of BKV 266 clearance varies among patients spanning period of time from several weeks to even years (7, 8) . the role of clonotype diversity and protective capacity of the adaptive cellular immune response remain so far 286 not completely resolved. Some studies suggest that diversity and size of the antigen-specific TCR repertoire 287 are two critical determinants for successful control of chronic infections and that the decreased repertoire 288 diversity in age correlates with the decline of immune responsiveness in ageing (10). 289
Although it is generally believed that a large T-cell clonotype diversity provides the optimal protection 290 (27,39), mice with reduced TCR diversity are capable of controlling LCMV or Sendai virus infections (40) 291
and differences in diversity of influenza-specific CD8 + T-cells were not reflected in differences in overall 292 functionality (41). On the other hand, an association between TCRβ chain high diversity and low incidence of 293 CMV and EBV reactivations has been observed in solid organ or hematopoietic stem cell transplant patients 294 such that higher diversity yields lower incidence (42-44). 295
In line with these data, we here demonstrated a negative correlation between diversity level and clearance time 296 of BKV infection. However, a single patient defied the observed association. We believe that the low diversity 297 level was substituted by a high level of functional fitness of BKV-specific T-cells. In fact, we observed a 298 nearly 10 times higher frequency of BKV-specific T-cells in the analyzed as compared to the other patients 299
and very low levels of PD1 or TIM3 expression on BKV-specific CD4 + T-cells at the peak of BKV viral load. 300
The large frequency and low diversity was reflected in a strong dominance of the first ten most abundant 301 BKV-specific clonotypes which indicates an expansion of particular T-cell clones. The relationship between 302 the strength of the TCR signal and the proliferation of the T-cell is well established (45). It is therefore 303 possible that highly specific T-cell clones dominate in this one patient, resulting in low diversity of the overall 304 BKV-specific repertoire. In a more general sense, it might be that most BKV-specific TCRs are of lower 305 avidity and that high avidity TCRs are rare and generated by chance. This also explains the observation, where 306 low diversity leads to longer clearance times: a broader TCR repertoire is better equipped to generate a 307 population of BKV-specific T-cells required to initiate and maintain the clearance of the virus (4,5). We are 308 currently in the process of elucidating the avidity of a select number of the identified BKV specific clonotypes. 309
An alternative explanation to the low diversity but fast clearance of patient 3 could be that the patient has a 310 particular set of HLA molecules, which allow strong presentation of immunogenic BKV epitopes. However, 311
the haplotypes of patient 3 were the same as for patient 4; at least on the level of allele group. This indicates 312 that the HLA haplotype alone is insufficient to explain the TCR diversity. 313
The expression of the exhaustion markers PD1 and TIM3 on the CD4 + T-cells displayed in both cases a 314 straight forward relationship with the clearance time, such that the absence of exhaustion markers was 315 associated with shorter clearance time. This makes it possible, that the fitness of the T-cells is a major player 316 in creating a pool of BKV controlling T-cells in addition to the repertoire diversity. Since both the repertoire 317 diversity and the expression of exhaustion markers correlated with the clearance rate, it is possible that one 318 effect depends on another one: low diversity leads to insufficient clearance and therefore to long-lasting BKV 319 reactivation with a subsequent sustained activation of BKV-specific T-cells. This long-lasting T-cell activation 320 could result in a high-level of exhaustion. Alternatively, the expression of exhaustion makers leading to a 321 functional impairment of T-cells might lead to a protracted viral elimination and contribute therefore to a 322 permanent activation of BKV. Such permanent antigenic stimuli can lead to clonal skewing with an expansion 323 of a few clones, similar to a phenomenon described for older patients with CMV reactivations (46). Although 324
our study provided first observations between T-cell functionality, duration of viral clearance, and T-cell 325 clonality ( Figure 6) ; the interplay between the T-cell exhaustion status and the TCR repertoire diversity is of 326 special interest and will be addressed in ongoing studies. 327
Our study is limited in that it is based on a small cohort of 7 kidney transplant patients, with TCRβ CDR3 data 328 available for only 5 of these 7 patients. This is arguably a very small cohort. However, the observed 329 associations had high correlation coefficients indicating small variance in the data, and thus demonstrating that 330 the findings presented here are robust, despite the small cohort. The associated p-values were likewise small, 331
confirming that the observations might not be per chance only. The viral load can fluctuate by up to one log, 332
but we generally observed a steady decline in BKV copies/ml after some maximal value. We therefore defined 333 the start of the clearance phase as the peak in BKV viremia. Other definitions might be valid, but they would 334 affect the clearance duration for all patients equally, and thereby not disturb the order of clearance times. 335
Though the results presented in our study are very encouraging, the small cohort size warrants caution. The 336 second limitation is the sampling schedule. Since the course of the viral reactivation is inherently 337 unpredictable, the acquisition of samples at the very early stage/and or peak of reactivation is very much a 338 case of "hit and miss". Future studies on a large patient cohort addressing the role of TCR diversity and T cell 339 exhaustion in general are required to validate our findings. To include the most relevant periods of BKV 340 reactivation and make such monitoring schedule logistically feasible, blood should be collected and stored as 341 isolated and frozen PBMCs at regular intervals. In summary, we propose that the exhaustion status of CD4 + T-342 cells affects the diversity of the antigen specific TCR repertoire resulting in prolonged clearance time after 343 BKV reactivation ( Figure 6 ). It will be interesting to see if this is a particular feature of the control of BKV in 344 a transplantation setting, or if this is general to chronic infections. 345
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